Inovio Pharmaceuticals (NASDAQ:INO) Stock Rating Upgraded by

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was upgraded by research analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Thursday, MarketBeat Ratings reports. The firm presently has a $4.00 price objective on the biopharmaceutical company’s stock. A number of other brokerages […]

Related Keywords

, Inovio Pharmaceuticals Inc , Inovio Pharmaceuticals , Inovio Pharmaceuticals Stock Performance , Fund Management Co , E Fund Management Co , Hsbc Holdings , Nasdaq , News Ratings For Inovio Pharmaceuticals Daily , Group Plc , Nuveen Asset Management , Get Free Report , General Group Plc , Asset Management , Fund Management , Inovio Pharmaceuticals Daily , Nasdaq Ino , Ino , Medical , Upgrade , Oppenheimer Holdings Inc ,